Loading stock data…
THC
$183.27+6.15 (+3.47%)
Market ClosedLast close May 1
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Tenet Healthcare Corporation in the Healthcare sector is trading at $183.27. The stock is currently 26% below its 52-week high of $247.21, remaining 7.0% below its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why THC maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$183.27
Potential Upside
105.8%
Whystock Fair Value$377.10
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus21 analysts
Mean target$253.38+38.3%
Range$213.00 – $288.00
Fundamentals
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$16.50B
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
12.17
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.50
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
35.17%
Volume
Today's trading volume
3.11M
Recent News
Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Cost management, outpatient unit helped Tenet weather volume headwinds in Q1
Executives said Tenet’s focus on managing expenses and growing high-acuity service lines helped it withstand poor volumes that battered some of its peers in the first quarter.
Tenet Healthcare Corporation Q1 2026 Earnings Call Summary
Moby summary of Tenet Healthcare Corporation's Q1 2026 earnings call
Tenet (THC) Q1 2026 Earnings Call Transcript
Saumya Sutaria: Thank you, Will, and good morning, everyone. As anticipated towards the end of last year, the operating environment is dynamic. There are payer mix shifts, seasonal effects, and insurance enrollment uncertainty in the exchanges and Medicaid that impact demand.
Tenet (THC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Tenet (THC) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.